![](/img/cover-not-exists.png)
340 A phase I study of the smoothened (SMO) antagonist LDE225 in combination with paclitaxel in patients with advanced solid tumors
Stathis, A., Hess, D., Xyrafas, A., Enoiu, M., Berardi, S., Moos, R. Von, Homicsko, K., Griguolo, G., Jörger, M., Mark, M., Ackermann, C., Sessa, C.Volume:
51
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)30203-9
Date:
September, 2015
File:
PDF, 59 KB
english, 2015